{
    "code": "02020461",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02020461",
    "time": "2020-02-25 12:27:51",
    "許可證字號": "衛署藥輸字第020461號",
    "註銷狀態": "已註銷",
    "註銷日期": "102\/12\/31",
    "註銷理由": "屆期未申請展延",
    "有效日期": "93\/05\/24",
    "發證日期": "83\/05\/24",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202046102",
    "中文品名": "美克羅西多注射劑",
    "英文品名": "MECHUROSEITO INJECTIONS",
    "適應症": "急性胰臟炎伴有蛋白分解酵素逸脫之胰臟疾患症狀之緩解？泛發性血管症。",
    "劑型": "243凍晶注射劑",
    "包裝": "小瓶",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "0707101100  呈春貿易股份有限公司",
        "申請商地址": "台北市忠孝東路４段２８５號６樓之１",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "5616002810",
            "成分名稱": "GABEXATE MESILATE",
            "含量描述": "100",
            "含量": "100.0000000000",
            "單位": "MG"
        }
    ]
}